Ophthalmology Times spoke with Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis about how her ...

The pandemic caused an overall decrease in the rates of the 10 most common ophthalmic procedures performed in 2020 when ...

Shan Lin, MD, speaks to the new MIGS entering the glaucoma space and providing additional options for patients and providers ...

Sonia H. Yoo, MD, a cornea, cataract, and refractive surgery specialist and a member of the planning committee for the ...

Inder Paul Singh, MD, speaks to the potential of artificial intelligence (AI) in the management of the glaucoma disease state ...

Andrew Iwach, MD, shares how Glaucoma 360 got its start and how today's meeting focuses on innovation that can benefit ...

Sunita Radhakrishnan, MD, shares insights on the use of electric neurostimulation and its potential use in the treatment of glaucoma, as evidenced by its current use in Europe and the upcoming trials ...

Patients with glaucoma who are using prostaglandin F (FP) receptor agonists to control their disease may experience ...

Patients commonly reported unexplained blurred or hazy vision postoperatively that requires further investigation ...

Researchers conducted a study to characterize ophthalmic adverse events associated with cosmetics and personal care products ...

Himani Goyal, MD, takes glaucoma care to the next level by embracing advancements that extend beyond traditional treatment ...

This research team evaluated the effectiveness of switching patients to faricimab treatment by assessing their outcomes after ...